Notice2022-26305

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 2, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 231 (Friday, December 2, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 231 (Friday, December 2, 2022)]
[Notices]
[Pages 74151-74152]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-26305]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-22CB]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Assessment for the Get Ahead of Sepsis 
(GAOS) Consumer and Healthcare Professional Campaign'' to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on January 31, 2022, to obtain comments from 
the public and affected agencies. CDC received two comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Assessment for the Get Ahead of Sepsis (GAOS) Consumer and 
Healthcare Professional Campaign--New--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Sepsis is a life threating emergency, and it is the body's 
overactive and toxic response to an infection. Each year 1.7 million 
adults in the United States develop sepsis, with 270,000 fatalities. 
Sepsis is the leading cause of death in hospitals and one out of three 
hospital fatalities are due to sepsis infection. Sepsis management in 
U.S. hospitals is the highest when compared to inpatient cost for all 
other medical conditions. Annual costs are estimated to be over $62 
billion.
    In media and public health campaigns, antimicrobial resistance and 
sepsis are rarely presented together which does not make their linkage 
apparent. It has been concluded that sepsis and antimicrobial 
stewardship should not be discussed in isolation. Surprisingly, 24% of 
adults in the U.S. have never heard of sepsis, so this presents a 
unique opportunity for future messaging campaigns.
    The goals of the Get Ahead of Sepsis (GAOS) educational campaign 
are to prevent and reduce infections that lead to sepsis and to 
optimize healthcare quality and patient safety by raising awareness, 
knowledge, and motivating behavior change related to sepsis prevention, 
early recognition, and appropriate treatment among consumer and 
healthcare professional (HCP) audiences. A panel survey will be 
utilized to recruit participants. Surveys will be distributed to 
consumer audiences and HCPs both before and after the media campaign 
and partner outreach.
    Consumer audiences include:
    (1) Cancer patients and their caregivers,
    (2) Patients who survived severe COVID-19 or sepsis and their 
caregivers,
    (3) Parents of children 12 and younger,
    (4) Adults who care for a family member age 65+, (5) Men aged 65+ 
with one or more chronic conditions, and (6) Healthy adults 65+
    HCP audiences include:
    (1) Emergency Medical Services personnel,
    (2) Nurse Practitioners and Physician Assistants who work at urgent 
care clinics,
    (3) Emergency Department triage nurses,
    (4) General medical ward staff,
    (5) Primary care physicians,
    (6) Long-term care (LTC) nurses, and
    (7) LTC medical technicians and sitters.
    This program evaluation will assist CDC in determining if the GAOS 
media campaign, along with partner outreach, was successful in raising 
knowledge and awareness and motivating behavior change among consumer 
and HCP audiences in select markets. The information gathered from this 
evaluation will also be used to inform refinement and implementation of 
the campaign (materials and tactics).
    CDC requests OMB approval for an estimated 1366 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Consumers.............................  GAOS Consumer...........             945               1           20/60
                                        Pre-Campaign web survey.

[[Page 74152]]

 
Consumers.............................  GAOS Consumer...........             945               1           20/60
                                        Post-Campaign web survey
HCPs..................................  GAOS HCP................            1103               1           20/60
                                        Pre-Campaign web survey.
HCPs..................................  GAOS HCP................            1103               1           20/60
                                        Post-Campaign web survey
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-26305 Filed 12-1-22; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on December 2, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.